Position in IBRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,012,388
+$6,573,484 QoQ
Shares Held
1,029,399
-16.4% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 403 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. IBRX ranks #54 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in IBRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,012,388 | 1,029,399 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $2,438,904 | 1,231,770 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,499,849 | 1,016,199 | Shares | Sole | 2025-11-13 | |
| 2022-06-30 | $1,494,253 | 401,681 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $1,853,792 | 304,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,025,111 | 207,917 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 NK | — | 32,745 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 NK | — | 1,689,963 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||